Market Overview

Milberg LLP Announces Pendency of Class Action Lawsuits Filed Against Peregrine Pharmaceuticals

Share:
Related PPHM
Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2015 Annual Meeting
Morning Market Gainers

Milberg LLP announces that class action lawsuits were filed in the United States District Court for the Central District of California on behalf of purchasers of Peregrine Pharmaceuticals, Inc. (“Peregrine”) (NASDAQ: PPHM) common stock during the period July 16, 2012 to September 26, 2012, (the “Class Period”).

Milberg LLP has created a website (http://www.PeregrineLawsuit.com) that seeks to answer common questions about shareholder class actions.

Posted-In: News FDA

 

Related Articles (PPHM)

Around the Web, We're Loving...